(Q52548809)

3 May 2018

title

FasL deficiency enhances the development of tumors in p53+/- mice. (English)

1 reference

3 May 2018

author name string

Michelle Embree-Ku

series ordinal

1

1 reference

3 May 2018

Kim Boekelheide

series ordinal

2

1 reference

3 May 2018

language of work or name

English

0 references

publication date

1 November 2002

1 reference

3 May 2018

published in

Toxicologic Pathology

1 reference

3 May 2018

volume

30

1 reference

3 May 2018

issue

6

1 reference

3 May 2018

page(s)

705-713

1 reference

3 May 2018

Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains

cites work

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

Transponder-Induced Sarcoma in the Heterozygous p53+/- Mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

The p53-deficient mouse: a model for basic and applied cancer studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

The p53 protein is an unusually shaped tetramer that binds directly to DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

Tumor spectrum analysis in p53-mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

Mutation and cancer: statistical study of retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

New models for assessing carcinogenesis: an ongoing process

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

A role for CD95 ligand in preventing graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230290166797

10.1080/01926230290166797

21 January 2018

Identifiers

DOI

1 reference

3 May 2018

1 reference

3 May 2018